GMRE Files 8-K on Material Agreement; Details Undisclosed

TL;DR

**GMRE filed an 8-K about a material agreement, but the actual details are missing, leaving investors in the dark.**

AI Summary

Global Medical REIT Inc. filed an 8-K on January 9, 2024, to report an "Entry into a Material Definitive Agreement" and "Financial Statements and Exhibits." While the filing confirms the company's registration on the NYSE under the trading symbol GMRE for its Common Stock, par value $0.001 per share, it does not disclose the specific details of the material agreement. This matters to investors because without the specifics of the agreement, it's impossible to assess its potential impact on the company's financial health or future prospects, leaving a key piece of information missing.

Why It Matters

Investors need to know the specifics of the 'Material Definitive Agreement' to understand its financial implications and potential impact on Global Medical REIT Inc.'s stock value. The lack of detail creates uncertainty.

Risk Assessment

Risk Level: medium — The filing indicates a material agreement but provides no details, creating uncertainty and potential risk for investors who cannot evaluate its impact.

Analyst Insight

Investors should await further disclosures from Global Medical REIT Inc. regarding the 'Material Definitive Agreement' before making any investment decisions, as the current filing lacks critical information to assess its impact.

Key Numbers

• $0.001 — Par value per share (The par value of Global Medical REIT Inc.'s Common Stock.)

Key Players & Entities

• Global Medical REIT Inc. (company) — the registrant filing the 8-K
• NYSE (company) — the exchange where GMRE's common stock is registered
• $0.001 (dollar_amount) — par value per share of common stock
• January 9, 2024 (date) — date of the earliest event reported and filing date

Forward-Looking Statements

• Global Medical REIT Inc. will file another 8-K or a subsequent filing to disclose the specific details of the 'Material Definitive Agreement'. (Global Medical REIT Inc.) — high confidence, target: Q1 2024

FAQ

Key Financial Figures

• $0.001 — h registered: Common Stock, par value $0.001 per share GMRE NYSE Series A Pref
• $300,000,000 — eds up to an aggregate dollar amount of $300,000,000 (the " Shares "). The Company also ente

Filing Documents

• tm242475d1_8k.htm (8-K) — 39KB
• tm242475d1_ex1-1.htm (EX-1.1) — 492KB
• tm242475d1_ex5-1.htm (EX-5.1) — 32KB
• tm242475d1_ex99-1.htm (EX-99.1) — 244KB
• tm242475d1_ex5-1img01.jpg (GRAPHIC) — 12KB
• tm242475d1_ex5-1img02.jpg (GRAPHIC) — 19KB
• 0001104659-24-002641.txt ( ) — 1219KB
• gmre-20240109.xsd (EX-101.SCH) — 3KB
• gmre-20240109_def.xml (EX-101.DEF) — 26KB
• gmre-20240109_lab.xml (EX-101.LAB) — 36KB
• gmre-20240109_pre.xml (EX-101.PRE) — 25KB
• tm242475d1_8k_htm.xml (XML) — 5KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On January 9, 2024, Global Medical REIT Inc. (the " Company ") and Global Medical REIT L.P., the Company's operating partnership (the " Operating Partnership "), entered into a Sales Agreement (the " Sales Agreement ") with (i) BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Berenberg Capital Markets LLC, Colliers Securities LLC, Compass Point Research & Trading, LLC, Janney Montgomery Scott LLC, Citizens JMP Securities, LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Samuel A. Ramirez & Company, Inc., Stifel, Nicolaus & Company, Incorporated, Truist Securities, Inc. and Wells Fargo Securities, LLC, as sales agents for the Company (the " Agents "), or principals (ii) BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Citizens JMP Securities, LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Stifel, Nicolaus & Company, Incorporated, Truist Securities, Inc. and Wells Fargo Securities, LLC, as forward sellers (in such capacity, each, a " Forward Seller " and collectively, the " Forward Sellers ") and (iii) Bank of Montreal, B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Citizens JMP Securities, LLC, JPMorgan Chase Bank, National Association, KeyBanc Capital Markets Inc., Stifel, Nicolaus & Company, Incorporated, Truist Bank and Wells Fargo Bank, National Association, as forward purchasers (in such capacity, each a " Forward Purchaser ," and together, the " Forward Purchasers "), pursuant to which the Company may offer and sell, from time to time, through the Agents or directly to the Agents as principals for their own accounts, or the Forward Purchasers may borrow and sell, from time to time, through the Forward Sellers, shares of the Company's common stock, $0.001 par value per share (" Common Stock "), with gross proceeds up to an aggregate dollar amount of $300,000,000 (the " Shares "). T

01 Financial Statement and Exhibits

Item 9.01 Financial Statement and Exhibits. (d) Exhibits Exhibit No. Description 1.1 Sales Agreement, dated January 9, 2024 by and among the Company, Global Medical REIT L.P. and each sales agent, forward seller and forward purchaser 5.1 Opinion of Venable LLP 23.1 Consent of Venable LLP (included in Exhibit 5.1) 99.1 Form of Master Forward Confirmation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 3

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Global Medical REIT Inc. By: /s/ Jamie A. Barber Jamie A. Barber Secretary and General Counsel Date: January 9, 2024 4

View Full Filing

View this 8-K filing on SEC EDGAR